Comparison of Efficacy of Metoclopramide , Promethazine and Prochloroperazine in the Treatment of Vertigo.

PHASE3RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

December 28, 2024

Study Completion Date

December 30, 2024

Conditions
Peripheral Vertigo
Interventions
DRUG

Metoclopramid ( 10mg), IM promethazine (25mg) , IM prochloroperazine( 12.5mg)

Each patient with vertigo symptoms will be registered in vertigo list after written consent taken. The ED doctor will take one paper from the vertigo list box and will write the case there including patient ID, date, age and symptoms. Assessment (VAS \& EEV) will be done in the pre- medication 0 min, and at 60 mins posts anti-vertigo medication. The medication will be provided blindly through the pharmacy. Any possible medication side effect and any possible further work up done for patient will be involved in each paper as ED doctor will put a tick near each point. Score will be written in papers as per patient evaluation of their symptoms grade from 1-10. The need for rescue medication ( betahisten or ondansetron ) will be recorded in the paper or is need eply manuver. Principle investigator in each centre will be responsible to collect the papers for analysis by end of each weeks.

Trial Locations (1)

968

RECRUITING

Al Nahdha hospital, AFH and Sohar hospital, Muscat

All Listed Sponsors
lead

Oman Medical Speciality Board

OTHER_GOV